Results 281 to 290 of about 84,355 (327)

Dynamic time warp of emotions in patients with cutaneous T-cell lymphoma treated with corticosteroids. [PDF]

JAAD Int
Koning ACAM, Ottevanger R, Vermeer MH, Meijer OC, Giltay EJ.   +4 more
europepmc   +1 more source

CD70: An emerging target for integrated cancer diagnosis and therapy

Clinical and Translational Medicine, Volume 15, Issue 7, July 2025.
CD70 is aberrantly overexpressed in diverse tumours with limited normal tissue expression, making it a compelling diagnostic and therapeutic target. Immuno‐PET/CT facilitates tumour detection, staging, and treatment monitoring. Multiple CD70‐targeted therapies are under early evaluation. Rational combination strategies are emerging to enhance antitumor
Jiatao Hu, Jinxin Li, Bo Yang, Siyi Wang, Yi Bao, Yiren Yang, Kun Qiao, Fei Guo, Xinxin Gan, Linhui Wang   +9 more
wiley   +1 more source

Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic. [PDF]

Acta Derm Venereol
Roccuzzo G, Macagno N, Sarda C, Pisano J, Ribero S, Fava P, Quaglino P.   +6 more
europepmc   +1 more source

A Case Series and Literature Review of Angiosarcoma With Malignant Effusion—A Challenging Cytologic Diagnosis With Dire Prognostic Implications

Diagnostic Cytopathology, Volume 53, Issue 7, Page E119-E126, July 2025.
ABSTRACT Angiosarcoma with malignant effusion is an uncommon yet clinically aggressive presentation, which poses as a diagnostic pitfall with its overlapping cytomorphologic features with metastatic adenocarcinoma. In this article, two cases reported in the literature were reviewed for cytology, immunocytochemistry, and clinical course.
Jamie C. Y. Lam, Iris Y. H. Liu, Joanna K. M. Ng, Joshua J. X. Li   +3 more
wiley   +1 more source

Impact of Postoperative Radiation Therapy Delay and Treatment Facility Location on Survival in Head and Neck Cancer Patients

Head &Neck, Volume 47, Issue 7, Page 1807-1815, July 2025.
ABSTRACT Background Time from surgery to initiation of postoperative radiation therapy (PORT) of less than 6 weeks was recently instituted as the first quality metric within head and neck cancer care. Methods We performed a retrospective single institution cohort study to investigate predictors of PORT delay and the impact of PORT delay on survival ...
Niketna Vivek, Rahul Sharma, Kavita Prasad, Kyle Mannion, Robert J. Sinard, Alexander Langerman, Eben Rosenthal, Sarah Rohde, Ryan Whitaker, Natalie Lockney, Michael C. Topf   +10 more
wiley   +1 more source

Author Correction: Cutaneous T cell lymphoma atlas reveals malignant T_H2 cells supported by a B cell-rich tumor microenvironment. [PDF]

Nat Immunol
Li R, Strobl J, Poyner EFM, Balbaa A, Torabi F, Mazin PV, Chipampe NJ, Stephenson E, Ramírez-Suástegi C, Shanmugiah VBM, Gardner L, Olabi B, Coulthard R, Botting RA, Zila N, Prigmore E, Gopee NH, Chroscik MA, Kritikaki E, Engelbert J, Goh I, Chan HM, Johnson HF, Ellis J, Rowe V, Tun W, Reynolds G, Yang D, Foster AR, Gambardella L, Winheim E, Admane C, Rumney B, Steele L, Jardine L, Nenonen J, Pickard K, Lumley J, Hampton P, Hu S, Liu F, Liu X, Horsfall D, Basurto-Lozada D, Grimble L, Bacon CM, Weatherhead SC, Brauner H, Wang Y, Bai F, Reynolds NJ, Allen JE, Jonak C, Brunner PM, Teichmann SA, Haniffa M.   +55 more
europepmc   +1 more source

Current Status of Revisions to the Lugano Classification in Lymphoma

Hematological Oncology, Volume 43, Issue 4, July 2025.
ABSTRACT In the decade since publication of the Lugano Classification (Cheson et al, J Clin Oncol 2014,32:3059–3068; Barrington et al, J Clin Oncol 2014, 32:3048–3058), major advances in lymphoma therapy and assessment, including metabolic tumor volume (MTV) and circulating tumor DNA (ctDNA) prompted a workshop at the International Conference on ...
The Organizing Committee of the Lugano Classification Workshop
wiley   +1 more source

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma. [PDF]

J Clin Oncol
Foss FM, Kim YH, Prince HM, Akilov OE, Querfeld C, Seminario-Vidal L, Fisher DC, Kuzel TM, Yannakou CK, Geskin LJ, Feldman T, Sokol L, Allen PB, Dang NH, Cabanillas F, Wong HK, Ooi CE, Xing D, Sauter N, Singh P, Czuczman M, Duvic M.   +21 more
europepmc   +1 more source

Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors

Immunity, Inflammation and Disease, Volume 13, Issue 7, July 2025.
My review paper described the struction of NLRP3 inflammasomes and the actived mechanism of them. Then, sumerized the NLRP3 inflammasomes' function of inflammatory diseases and cancer. ABSTRACT The nucleotide‐binding and oligomerization domain‐like receptors (NLRs) are pattern recognition receptors.
Le‐Lan Gong, He‐Jiang Zhou, Quan‐Ming Zhao, Ning Xu, Feng‐Chang Huang, Ling‐Yan Su, Wen‐Liang Li   +6 more
wiley   +1 more source

Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies. [PDF]

Dermatol Ther (Heidelb)
Davis MS, Spencer RK, Johnson CE, Elhage KG, Jin JQ, Hakimi M, Bhutani T, Liao W.   +7 more
europepmc   +1 more source